Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Ryan

Showing results (231-240 of 274) with videos related to

Pageof 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II studyAndrew X Zhu, Dushyant V Sahani, Dan G Duda, et al.
The Oncologist|May 10, 2013
FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experienceJason E Faris, Lawrence S Blaszkowsky, Shaunagh McDermott, et al.
The Oncologist|August 22, 2020
Revisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET-Amplified Esophagogastric CancersSurendra Pal Chaudhary, Eunice L Kwak, Katie L Hwang, et al.
Journal of the National Cancer Institute|September 17, 2015
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical TrialCarmen J Allegra, Greg Yothers, Michael J O'Connell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2017
Use of Angiotensin System Inhibitors Is Associated with Immune Activation and Longer Survival in Nonmetastatic Pancreatic Ductal AdenocarcinomaHao Liu, Kamila Naxerova, Matthias Pinter, et al.
JCO Oncology Practice|May 27, 2021
Care Patterns and Overall Survival in Patients With Early-Onset Metastatic Colorectal CancerKatie Kanter, Madeleine Fish, Gianluca Mauri, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2017
An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinomaMark Kalinich, Irun Bhan, Tanya T Kwan, et al.
The Oncologist|August 7, 2015
Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic CholangiocarcinomaLipika Goyal, Aparna Govindan, Rahul A Sheth, et al.
Annals of Surgery|January 20, 2015
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancerCristina R Ferrone, Giovanni Marchegiani, Theodore S Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2022
Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment ResponseToni T Seppälä, Jacquelyn W Zimmerman, Reecha Suri, et al.
Pageof 28

Showing results (231-240 of 274) with videos related to

Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II studyAndrew X Zhu, Dushyant V Sahani, Dan G Duda, et al.
The Oncologist|May 10, 2013
FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experienceJason E Faris, Lawrence S Blaszkowsky, Shaunagh McDermott, et al.
The Oncologist|August 22, 2020
Revisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET-Amplified Esophagogastric CancersSurendra Pal Chaudhary, Eunice L Kwak, Katie L Hwang, et al.
Journal of the National Cancer Institute|September 17, 2015
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical TrialCarmen J Allegra, Greg Yothers, Michael J O'Connell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2017
Use of Angiotensin System Inhibitors Is Associated with Immune Activation and Longer Survival in Nonmetastatic Pancreatic Ductal AdenocarcinomaHao Liu, Kamila Naxerova, Matthias Pinter, et al.
JCO Oncology Practice|May 27, 2021
Care Patterns and Overall Survival in Patients With Early-Onset Metastatic Colorectal CancerKatie Kanter, Madeleine Fish, Gianluca Mauri, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2017
An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinomaMark Kalinich, Irun Bhan, Tanya T Kwan, et al.
The Oncologist|August 7, 2015
Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic CholangiocarcinomaLipika Goyal, Aparna Govindan, Rahul A Sheth, et al.
Annals of Surgery|January 20, 2015
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancerCristina R Ferrone, Giovanni Marchegiani, Theodore S Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2022
Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment ResponseToni T Seppälä, Jacquelyn W Zimmerman, Reecha Suri, et al.
Pageof 28